ASTRANA HEALTH INC
ASTHNASDAQTrading Snapshot
- Day Range
- $34.35 – $35.08
- 52-Week Range
- $18.08 – $51.60
- Volume
- $2.45B
- Avg Volume
- $1.94B
- Shares Outstanding
- 49.6M
- Next Earnings
- Oct 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $3.54B
- Last Q Revenue
- $857M
- P/E Ratio
- 61.2
- P/S Ratio
- 0.5x
- EPS (TTM)
- $0.61
- Dividend Yield
- 0.14%
Why Investors Own ASTH
- ✓High-growth profile — revenue up +18.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 76% gross margin and 20% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ASTRANA HEALTH INC
A company profile for ASTRANA HEALTH INC isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $47 to $55.
Barclays Maintains Overweight on Astrana Health, Raises Price Target to $53
Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Overweight and raises the price target from $50 to $53.
Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript
Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call August 6, 2026 5:30 PM EDTCompany ParticipantsBrandon Sim - President & CEOChan Basho - CFO, COO &...
Astrana Health (NASDAQ:ASTH) Falls on Q2 Revenue Miss Despite Earnings Beat
Astrana Health (ASTH) beats Q2 EPS but misses revenue; stock dips in after-hours. Revenue $972.5M vs $1.01B expected.
Astrana Health, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-06. The following slide deck was published by Astrana Health, Inc.
Astrana Health Sees Q3 Sales $1.000B-$1.030B vs $1.021B Est
Astrana Health (NASDAQ:ASTH) sees Q3 sales of $1.000 billion-$1.030 billion vs $1.021 billion analyst estimate.